{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T22:40:03Z","timestamp":1794955203206,"version":"4.9.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"13","license":[{"start":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T00:00:00Z","timestamp":1757894400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T00:00:00Z","timestamp":1757894400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100007368","name":"Fondazione Pisa","doi-asserted-by":"publisher","award":["REDISCOVER project"],"award-info":[{"award-number":["REDISCOVER project"]}],"id":[{"id":"10.13039\/100007368","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1245\/s10434-025-18212-w","type":"journal-article","created":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T15:28:57Z","timestamp":1757950137000},"page":"9995-10006","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Survival Benefit of Surgery versus Oncology-Only Therapy in Artery-Involving Borderline Resectable and Locally Advanced Pancreatic Cancer"],"prefix":"10.1245","volume":"32","author":[{"given":"Niccol\u00f2","family":"Napoli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allegra","family":"Ripolli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele F.","family":"Kauffmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Ginesini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Casadei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Coppola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vyacheslav","family":"Egorov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichi","family":"Nagakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Rangelova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilio","family":"Vicente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ugo","family":"Boggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"and the Rediscover Study Group members","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Alfieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc G.","family":"Besselink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier R.","family":"Busch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amjad","family":"Khalil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Hadjittofi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe Kito","family":"Fusai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedetto","family":"Ielpo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Tsiotos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kongyuan","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Zerbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,15]]},"reference":[{"key":"18212_CR1","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1007\/s13304-024-01956-7","volume":"76","author":"M Ventin","year":"2024","unstructured":"Ventin M, Ferrone CR. REDISCOVER the change in surgical management of pancreatic cancer from anatomy to biology. Updates Surg. 2024;76:1569\u201371. https:\/\/doi.org\/10.1007\/s13304-024-01956-7.","journal-title":"Updates Surg."},{"key":"18212_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s13304-023-01626-0","volume":"76","author":"SQ Yang","year":"2024","unstructured":"Yang SQ, Zou RQ, Dai YS, Li FY, Hu HJ. Comparison of the upfront surgery and neoadjuvant therapy in resectable and borderline resectable pancreatic cancer: an updated systematic review and meta-analysis. Updates Surg. 2024;76:1\u201315. https:\/\/doi.org\/10.1007\/s13304-023-01626-0.","journal-title":"Updates Surg."},{"key":"18212_CR3","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1097\/SLA.0000000000006248","volume":"280","author":"U Boggi","year":"2024","unstructured":"Boggi U, Kauffmann EF, Napoli N, et al. REDISCOVER international guidelines on the perioperative care of surgical patients with borderline-resectable and locally advanced pancreatic cancer. Ann Surg. 2024;280:56\u201365. https:\/\/doi.org\/10.1097\/SLA.0000000000006248.","journal-title":"Ann Surg."},{"key":"18212_CR4","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1007\/s13304-024-01860-0","volume":"76","author":"U Boggi","year":"2024","unstructured":"Boggi U, Kauffmann EF, Napoli N, et al. REDISCOVER guidelines for borderline-resectable and locally advanced pancreatic cancer: management algorithm, unanswered questions, and future perspectives. Updates Surg. 2024;76:1573\u201391. https:\/\/doi.org\/10.1007\/s13304-024-01860-0.","journal-title":"Updates Surg."},{"key":"18212_CR5","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s13304-023-01692-4","volume":"76","author":"OJ Shah","year":"2024","unstructured":"Shah OJ, Singh M. Developments in pancreatic cancer surgery. Updates Surg. 2024;76:17\u201322. https:\/\/doi.org\/10.1007\/s13304-023-01692-4.","journal-title":"Updates Surg."},{"key":"18212_CR6","doi-asserted-by":"publisher","first-page":"6111","DOI":"10.1097\/JS9.0000000000000971","volume":"110","author":"N Napoli","year":"2023","unstructured":"Napoli N, Kauffmann EF, Lombardo C, et al. Postoperative results, learning curve, and outcomes of pancreatectomy with arterial resection: a single-center retrospective cohort study on 236 procedures. Int J Surg. 2023;110:6111\u2013625. https:\/\/doi.org\/10.1097\/JS9.0000000000000971.","journal-title":"Int J Surg."},{"key":"18212_CR7","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1093\/bjs\/znac363","volume":"110","author":"U Boggi","year":"2023","unstructured":"Boggi U, Napoli N, Kauffmann EF, et al. Pancreatectomy with resection and reconstruction of the superior mesenteric artery. Br J Surg. 2023;110:901\u20134. https:\/\/doi.org\/10.1093\/bjs\/znac363.","journal-title":"Br J Surg."},{"key":"18212_CR8","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1097\/SLA.0000000000004054","volume":"275","author":"M Loos","year":"2022","unstructured":"Loos M, Kester T, Klaiber U, et al. Arterial resection in pancreatic cancer surgery: effective after a learning curve. Ann Surg. 2022;275:759\u201368. https:\/\/doi.org\/10.1097\/SLA.0000000000004054.","journal-title":"Ann Surg."},{"key":"18212_CR9","doi-asserted-by":"publisher","first-page":"4309","DOI":"10.1097\/JS9.0000000000000742","volume":"109","author":"K Xue","year":"2023","unstructured":"Xue K, Huang X, Zhao P, Zhang Y, Tian B. Perioperative and long-term survival outcomes of pancreatectomy with arterial resection in borderline resectable or locally advanced pancreatic cancer following neoadjuvant therapy: a systematic review and meta-analysis. Int J Surg. 2023;109:4309\u201321. https:\/\/doi.org\/10.1097\/JS9.0000000000000742.","journal-title":"Int J Surg."},{"key":"18212_CR10","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1097\/SLA.0b013e31823ac299","volume":"254","author":"N Mollberg","year":"2011","unstructured":"Mollberg N, Rahbari NN, Koch M, et al. Arterial resection during pancreatectomy for pancreatic cancer: a systematic review and meta-analysis. Ann Surg. 2011;254:882\u201393. https:\/\/doi.org\/10.1097\/SLA.0b013e31823ac299.","journal-title":"Ann Surg."},{"key":"18212_CR11","doi-asserted-by":"publisher","first-page":"48","DOI":"10.21037\/cco-21-39","volume":"10","author":"A Rebelo","year":"2021","unstructured":"Rebelo A, Ronellenfitsch U, D\u00f6bereiner J, Ukkat J, Kleeff J. Do arterial resections improve survival in pancreatic cancer?-A narrative review. Chin Clin Oncol. 2021;10:48. https:\/\/doi.org\/10.21037\/cco-21-39.","journal-title":"Chin Clin Oncol."},{"key":"18212_CR12","unstructured":"NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines\u00ae). Pancreatic Adenocarcinoma. Version 2.2025 \u2014 February 3, 2025. Accessed 9 Mar 2025 (https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/pancreatic.pdf)"},{"key":"18212_CR13","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1016\/j.ijsu.2014.07.013","volume":"12","author":"E von Elm","year":"2014","unstructured":"von Elm E, Altman DG, Egger M, et al. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Int J Surg. 2014;12:1495\u20139. https:\/\/doi.org\/10.1016\/j.ijsu.2014.07.013.","journal-title":"Int J Surg."},{"issue":"96","key":"18212_CR14","doi-asserted-by":"publisher","first-page":"106165","DOI":"10.1016\/j.ijsu.2021.106165","volume":"2021","author":"Mathew G and Agha R, for the STROCSS Group. STROCSS","year":"2021","unstructured":"Mathew G and Agha R, for the STROCSS Group. STROCSS. Strengthening the reporting of cohort, cross-sectional and case-control studies in Surgery. Int J Surg. 2021;2021(96):106165. https:\/\/doi.org\/10.1016\/j.ijsu.2021.106165.","journal-title":"Int J Surg"},{"key":"18212_CR15","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","volume":"240","author":"D Dindo","year":"2004","unstructured":"Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205\u201313. https:\/\/doi.org\/10.1097\/01.sla.0000133083.54934.ae.","journal-title":"Ann Surg."},{"key":"18212_CR16","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.surg.2016.11.014","volume":"161","author":"C Bassi","year":"2017","unstructured":"Bassi C, Marchegiani G, Dervenis C, et al. The 2016 update of the international study group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 tears after. Surgery. 2017;161:584\u201391. https:\/\/doi.org\/10.1016\/j.surg.2016.11.014.","journal-title":"Surgery."},{"key":"18212_CR17","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.surg.2007.02.001","volume":"142","author":"MN Wente","year":"2007","unstructured":"Wente MN, Veit JA, Bassi C, et al. Postpancreatectomy hemorrhage (PPH): an international study group of pancreatic surgery (ISGPS) definition. Surgery. 2007;142:20\u20135. https:\/\/doi.org\/10.1016\/j.surg.2007.02.001.","journal-title":"Surgery."},{"key":"18212_CR18","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/j.surg.2007.05.005","volume":"142","author":"MN Wente","year":"2007","unstructured":"Wente MN, Bassi C, Dervenis C, et al. Delayed gastric emptying (DGE) after pancreatic surgery: a suggested definition by the international study group of pancreatic surgery (ISGPS). Surgery. 2007;142:761\u20138. https:\/\/doi.org\/10.1016\/j.surg.2007.05.005.","journal-title":"Surgery."},{"key":"18212_CR19","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/j.annonc.2023.08.009","volume":"34","author":"T Conroy","year":"2023","unstructured":"Conroy T, Pfeiffer P, Vilgrain V, et al. Pancreatic cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol. 2023;34:987\u20131002. https:\/\/doi.org\/10.1016\/j.annonc.2023.08.009.","journal-title":"Ann Oncol."},{"key":"18212_CR20","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1056\/NEJMoa2208470","volume":"388","author":"JH Strickler","year":"2023","unstructured":"Strickler JH, Satake H, George TJ, et al. Sotorasib in KRAS p. G12C-mutated advanced pancreatic cancer. N Engl J Med. 2023;388:33\u201343. https:\/\/doi.org\/10.1056\/NEJMoa2208470.","journal-title":"N Engl J Med."},{"key":"18212_CR21","doi-asserted-by":"publisher","first-page":"799","DOI":"10.32604\/or.2024.045356","volume":"32","author":"S Stickler","year":"2024","unstructured":"Stickler S, Rath B, Hamilton G. Targeting KRAS in pancreatic cancer. Oncol Res. 2024;32:799\u2013805. https:\/\/doi.org\/10.32604\/or.2024.045356.","journal-title":"Oncol Res."},{"key":"18212_CR22","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1038\/s41591-024-02903-0","volume":"30","author":"A Singhal","year":"2024","unstructured":"Singhal A, Li BT, O\u2019Reilly EM. Targeting KRAS in cancer. Nat Med. 2024;30:969\u201383. https:\/\/doi.org\/10.1038\/s41591-024-02903-0.","journal-title":"Nat Med."},{"key":"18212_CR23","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1056\/NEJMoa1903387","volume":"381","author":"T Golan","year":"2019","unstructured":"Golan T, Hammel P, Reni M, et al. Maintenance Olaparib for germline BRCA-mutated metastatic pancreatic cancer. N Engl J Med. 2019;381:317\u201327. https:\/\/doi.org\/10.1056\/NEJMoa1903387.","journal-title":"N Engl J Med."},{"key":"18212_CR24","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1001\/jamaoncol.2021.0057","volume":"7","author":"M Reyngold","year":"2021","unstructured":"Reyngold M, O\u2019Reilly EM, Varghese AM, et al. Association of ablative radiation therapy with survival among patients with inoperable pancreatic cancer. JAMA Oncol. 2021;7:735\u20138. https:\/\/doi.org\/10.1001\/jamaoncol.2021.0057.","journal-title":"JAMA Oncol."},{"key":"18212_CR25","doi-asserted-by":"publisher","first-page":"3444","DOI":"10.1245\/s10434-022-13043-5","volume":"30","author":"B Lee","year":"2023","unstructured":"Lee B, Yoon YS, Kang M, et al. Validation of the anatomical and biological definitions of borderline resectable pancreatic cancer according to the 2017 international consensus for survival and recurrence in patients with pancreatic ductal adenocarcinoma undergoing upfront surgery. Ann Surg Oncol. 2023;30:3444\u201354. https:\/\/doi.org\/10.1245\/s10434-022-13043-5.","journal-title":"Ann Surg Oncol."},{"key":"18212_CR26","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1001\/jamasurg.2024.2485","volume":"159","author":"S Crippa","year":"2024","unstructured":"Crippa S, Malleo G, Mazzaferro V, et al. Futility of up-front resection for anatomically resectable pancreatic cancer. JAMA Surg. 2024;159:1139\u201347. https:\/\/doi.org\/10.1001\/jamasurg.2024.2485.","journal-title":"JAMA Surg."},{"key":"18212_CR27","doi-asserted-by":"publisher","first-page":"41549","DOI":"10.1038\/srep41549","volume":"7","author":"A Hann","year":"2017","unstructured":"Hann A, Bohle W, Egger J, Zoller W. Feasibility of alternating induction and maintenance chemotherapy in pancreatic cancer. Sci Rep. 2017;7:41549. https:\/\/doi.org\/10.1038\/srep41549.","journal-title":"Sci Rep."},{"key":"18212_CR28","doi-asserted-by":"publisher","DOI":"10.1093\/bjsopen\/zrad137","author":"I Farnes","year":"2023","unstructured":"Farnes I, Kleive D, Verbeke CS, et al. Resection rates and intention-to-treat outcomes in borderline and locally advanced pancreatic cancer: real-world data from a population-based, prospective cohort study (NORPACT-2). BJS Open. 2023. https:\/\/doi.org\/10.1093\/bjsopen\/zrad137.","journal-title":"BJS Open"},{"key":"18212_CR29","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.hpb.2018.07.017","volume":"21","author":"M Del Chiaro","year":"2019","unstructured":"Del Chiaro M, Rangelova E, Halimi A, et al. Pancreatectomy with arterial resection is superior to palliation in patients with borderline resectable or locally advanced pancreatic cancer. HPB (Oxford). 2019;21:219\u201325. https:\/\/doi.org\/10.1016\/j.hpb.2018.07.017.","journal-title":"HPB (Oxford)."},{"issue":"7","key":"18212_CR30","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1097\/MPA.0000000000001592","volume":"49","author":"M Cecchini","year":"2020","unstructured":"Cecchini M, Miccio JA, Pahade J, et al. A single-institution experience of induction 5-fluorouracil, Leucovorin, irinotecan, and Oxaliplatin followed by surgery versus consolidative radiation for borderline and locally advanced Unresectable pancreatic cancer. Pancreas. 2020;49(7):904\u201311. https:\/\/doi.org\/10.1097\/MPA.0000000000001592.","journal-title":"Pancreas."},{"key":"18212_CR31","doi-asserted-by":"publisher","unstructured":"Stoop TF, Seelen LWF, van 't Land FR, et al. Nationwide implementation of the international multidisciplinary best-practice for locally advanced pancreatic cancer (PREOPANC-4): study protocol. BMC Cancer. 2025;25:299. https:\/\/doi.org\/10.1186\/s12885-025-13554-w.","DOI":"10.1186\/s12885-025-13554-w"},{"key":"18212_CR32","doi-asserted-by":"publisher","first-page":"3227","DOI":"10.1002\/ijc.31628","volume":"143","author":"L Huang","year":"2018","unstructured":"Huang L, Jansen L, Balavarca Y, et al. Nonsurgical therapies for resected and unresected pancreatic cancer in Europe and USA in 2003\u20132014: a large international population-based study. Int J Cancer. 2018;143:3227\u201339. https:\/\/doi.org\/10.1002\/ijc.31628.","journal-title":"Int J Cancer."},{"key":"18212_CR33","doi-asserted-by":"publisher","first-page":"562","DOI":"10.4143\/crt.2017.105","volume":"50","author":"JS Chang","year":"2018","unstructured":"Chang JS, Chiu YF, Yu JC, Chen LT, Ch\u2019ang HJ. The role of consolidation chemoradiotherapy in locally advanced pancreatic cancer receiving chemotherapy: an updated systematic review and meta-analysis. Cancer Res Treat. 2018;50:562\u201374. https:\/\/doi.org\/10.4143\/crt.2017.105.","journal-title":"Cancer Res Treat."},{"key":"18212_CR34","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.ijrobp.2016.10.030","volume":"97","author":"F Petrelli","year":"2017","unstructured":"Petrelli F, Comito T, Ghidini A, Torri V, Scorsetti M, Barni S. Stereotactic body radiation therapy for locally advanced pancreatic cancer: a systematic review and pooled analysis of 19 trials. Int J Radiat Oncol Biol Phys. 2017;97:313\u201322. https:\/\/doi.org\/10.1016\/j.ijrobp.2016.10.030.","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"18212_CR35","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.hpb.2015.11.005","volume":"18","author":"G Balzano","year":"2016","unstructured":"Balzano G, Capretti G, Callea G, Cant\u00f9 E, Carle F, Pezzilli R. Overuse of surgery in patients with pancreatic cancer. A Nationwide Anal Italy HPB (Oxford). 2016;18:470\u20138. https:\/\/doi.org\/10.1016\/j.hpb.2015.11.005.","journal-title":"A Nationwide Anal Italy. HPB (Oxford)"},{"key":"18212_CR36","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1097\/SLA.0000000000001693","volume":"264","author":"U Nimptsch","year":"2016","unstructured":"Nimptsch U, Krautz C, Weber GF, Mansky T, Gr\u00fctzmann R. Nationwide in-hospital mortality following pancreatic surgery in Germany is higher than anticipated. Ann Surg. 2016;264:1082\u201390. https:\/\/doi.org\/10.1097\/SLA.0000000000001693.","journal-title":"Ann Surg."},{"key":"18212_CR37","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1097\/SLA.0000000000002399","volume":"266","author":"O Farges","year":"2017","unstructured":"Farges O, Bendersky N, Truant S, Delpero JR, Pruvot FR, Sauvanet A. The theory and practice of pancreatic surgery in France. Ann Surg. 2017;266:797\u2013804. https:\/\/doi.org\/10.1097\/SLA.0000000000002399.","journal-title":"Ann Surg."},{"key":"18212_CR38","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1097\/SLA.0000000000003468","volume":"270","author":"FI Macedo","year":"2019","unstructured":"Macedo FI, Ryon E, Maithel SK, et al. Survival outcomes associated with clinical and pathological response following neoadjuvant FOLFIRINOX or gemcitabine\/nab-paclitaxel chemotherapy in resected pancreatic cancer. Ann Surg. 2019;270:400\u201313. https:\/\/doi.org\/10.1097\/SLA.0000000000003468.","journal-title":"Ann Surg."},{"key":"18212_CR39","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1097\/SLA.0000000000005430","volume":"275","author":"J Yamaguchi","year":"2022","unstructured":"Yamaguchi J, Yokoyama Y, Fujii T, et al. Results of a phase ii study on the use of neoadjuvant chemotherapy (FOLFIRINOX or GEM\/nab-PTX) for borderline-resectable pancreatic cancer (NUPAT-01). Ann Surg. 2022;275:1043\u20139. https:\/\/doi.org\/10.1097\/SLA.0000000000005430.","journal-title":"Ann Surg."},{"key":"18212_CR40","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1001\/jamasurg.2020.2286","volume":"155","author":"G Perri","year":"2020","unstructured":"Perri G, Prakash L, Qiao W, et al. Response and survival associated with first-line Folfirinox vs gemcitabine and nab-paclitaxel chemotherapy for localized pancreatic ductal adenocarcinoma. JAMA Surg. 2020;155:832\u20139. https:\/\/doi.org\/10.1001\/jamasurg.2020.2286.","journal-title":"JAMA Surg."},{"key":"18212_CR41","first-page":"75","volume":"19","author":"BC Chapman","year":"2018","unstructured":"Chapman BC, Gleisner A, Rigg D, et al. Perioperative and survival outcomes following neoadjuvant Folfirinox versus gemcitabine Abraxane in patients with pancreatic adenocarcinoma. JOP. 2018;19:75\u201385.","journal-title":"JOP."},{"key":"18212_CR42","doi-asserted-by":"publisher","first-page":"2744","DOI":"10.1245\/s10434-017-5975-3","volume":"24","author":"I Epelboym","year":"2017","unstructured":"Epelboym I, Zenati MS, Hamad A, et al. Analysis of perioperative chemotherapy in resected pancreatic cancer: identifying the number and sequence of chemotherapy cycles needed to optimize survival. Ann Surg Oncol. 2017;24:2744\u201351. https:\/\/doi.org\/10.1245\/s10434-017-5975-3.","journal-title":"Ann Surg Oncol."},{"key":"18212_CR43","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1097\/SLA.0000000000003284","volume":"273","author":"MJ Truty","year":"2021","unstructured":"Truty MJ, Kendrick ML, Nagorney DM, et al. Factors predicting response, perioperative outcomes, and survival following total neoadjuvant therapy for borderline\/locally advanced pancreatic cancer. Ann Surg. 2021;273:341\u20139. https:\/\/doi.org\/10.1097\/SLA.0000000000003284.","journal-title":"Ann Surg."},{"key":"18212_CR44","doi-asserted-by":"publisher","first-page":"e677","DOI":"10.1097\/SLA.0000000000005830","volume":"278","author":"VS Wu","year":"2023","unstructured":"Wu VS, Elshami M, Stitzel HJ, et al. Why the treatment sequence matters: interplay between chemotherapy cycles received, cumulative dose intensity, and survival in resected early-stage pancreas cancer. Ann Surg. 2023;278:e677\u201384. https:\/\/doi.org\/10.1097\/SLA.0000000000005830.","journal-title":"Ann Surg."},{"key":"18212_CR45","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.hpb.2018.01.001","volume":"20","author":"E van Veldhuisen","year":"2018","unstructured":"van Veldhuisen E, Vogel JA, Klompmaker S, et al. Added value of CA19-9 response in predicting resectability of locally advanced pancreatic cancer following induction chemotherapy. HPB (Oxford). 2018;20:605\u201311. https:\/\/doi.org\/10.1016\/j.hpb.2018.01.001.","journal-title":"HPB (Oxford)."},{"key":"18212_CR46","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/S1470-2045(08)70001-9","volume":"9","author":"V Hess","year":"2008","unstructured":"Hess V, Glimelius B, Grawe P, et al. CA 19\u20139 tumour-marker response to chemotherapy in patients with advanced pancreatic cancer enrolled in a randomised controlled trial. Lancet Oncol. 2008;9:132\u20138. https:\/\/doi.org\/10.1016\/S1470-2045(08)70001-9.","journal-title":"Lancet Oncol."},{"key":"18212_CR47","doi-asserted-by":"publisher","unstructured":"Alvikas J, Hamed A, Tirukkovalur N, et al. Survival prediction for CA19-9 non-producers with resected pancreatic cancer. HPB (Oxford). 2025;S1365-182X(25)00611-2. https:\/\/doi.org\/10.1016\/j.hpb.2025.05.007.","DOI":"10.1016\/j.hpb.2025.05.007"},{"issue":"3","key":"18212_CR48","doi-asserted-by":"publisher","first-page":"730","DOI":"10.2214\/AJR.20.24567","volume":"217","author":"A Panda","year":"2021","unstructured":"Panda A, Garg I, Truty MJ, et al. Borderline Resectable and locally advanced pancreatic cancer: FDG PET\/MRI and CT Tumor metrics for assessment of pathologic response to neoadjuvant therapy and prediction of survival. AJR Am J Roentgenol. 2021;217(3):730\u201340. https:\/\/doi.org\/10.2214\/AJR.20.24567.","journal-title":"AJR Am J Roentgenol."},{"key":"18212_CR49","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1007\/s13304-023-01587-4","volume":"75","author":"N Napoli","year":"2023","unstructured":"Napoli N, Kauffmann EF, Ginesini M, et al. Ca 125 is an independent prognostic marker in resected pancreatic cancer of the head of the pancreas. Updates Surg. 2023;75:1481\u201396. https:\/\/doi.org\/10.1007\/s13304-023-01587-4.","journal-title":"Updates Surg."},{"key":"18212_CR50","doi-asserted-by":"publisher","first-page":"e1278","DOI":"10.1097\/SLA.0000000000005395","volume":"277","author":"K Omiya","year":"2023","unstructured":"Omiya K, Oba A, Inoue Y, et al. Serum DUPAN-2 could be an alternative biological marker for ca19-9 nonsecretors with pancreatic cancer. Ann Surg. 2023;277:e1278\u201383. https:\/\/doi.org\/10.1097\/SLA.0000000000005395.","journal-title":"Ann Surg."},{"key":"18212_CR51","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1097\/SLA.0000000000002753","volume":"270","author":"G Gemenetzis","year":"2019","unstructured":"Gemenetzis G, Groot VP, Blair AB, et al. Survival in locally advanced pancreatic cancer after neoadjuvant therapy and surgical resection. Ann Surg. 2019;270:340\u20137. https:\/\/doi.org\/10.1097\/SLA.0000000000002753.","journal-title":"Ann Surg."},{"key":"18212_CR52","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1002\/jhbp.1184","volume":"30","author":"T Takeda","year":"2023","unstructured":"Takeda T, Sasaki T, Okamoto T, et al. Outcomes of pancreatic cancer with liver oligometastasis. J Hepatobiliary Pancreat Sci. 2023;30:229\u201339. https:\/\/doi.org\/10.1002\/jhbp.1184.","journal-title":"J Hepatobiliary Pancreat Sci."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-18212-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-025-18212-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-18212-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T14:17:27Z","timestamp":1762352247000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-025-18212-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,15]]},"references-count":52,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["18212"],"URL":"https:\/\/doi.org\/10.1245\/s10434-025-18212-w","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,15]]},"assertion":[{"value":"10 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}